Related Experiment Video
Updated: Jun 28, 2026

Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
Blood glucose monitoring is associated with better glycemic control in type 2 diabetes: a database study
Glen H Murata1, William C Duckworth, Jayendra H Shah
1New Mexico VA Health Care System, Albuquerque, NM 87108, USA.
Background:
The value of self-monitoring blood glucose (SMBG) in type 2 diabetes is controversial.
Objective:
To determine SMBG testing rates are positively associated with glycemic control in veterans on oral hypoglycemic agents (OHA).
Design:
Observational database study.
Subjects:
Southwestern Healthcare Network veterans taking OHA in 2002 and followed through the end of 2004.
Measurements:
OHA and glucose test strip (GTS) prescriptions were derived from pharmacy files. Subjects were categorized into five groups according to their end-of-study treatment status: group 1 (no medication changes), group 2 (increased doses of initial OHA), group 3 (started new OHA), group 4 (both OHA interventions), and group 5 (initiated insulin). We then used multiple linear regression analyses to examine the relationship between the SMBG testing rate and hemoglobin A1c (HbA1c) within each group.
Results:
We evaluated 5,862 patients with a mean follow-up duration of 798 +/- 94 days. Overall, 44.2% received GTS. Ultimately, 47% of subjects ended up in group 1, 21% in group 2, 9% in group 3, 8% in group 4, and 16% in group 5. A univariate analysis showed no association between the SMBG testing rate and HbA1c. However, after stratifying by group and adjusting for initial OHA dose, we found that more frequent testing was associated with a significantly lower HbA1c in groups 1, 4, and 5. The effect ranged from -0.22% to -0.94% for every ten GTS/week.
Conclusions:
Higher SMBG testing rates were associated with lower HbA1c, but only when stratifying the analyses to control for treatment intensification.
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Hyperglycemia
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes: Symptoms, Diagnosis, and Complications